Entero Healthcare Solutions Limited — PPTs, 12-11-2025: Investor Presentation

Entero Healthcare delivered strong Q2 & H1 FY26 financial results. Q2 revenue surged 21% YoY to Rs. 1,571 Cr, with H1 revenue climbing 24% to Rs. 2,975 Cr. Gross margin improved to 10.2% (Q2) and EBITDA margin hit 4.0%, showcasing robust operational efficiency. Profit After Tax (PAT) margin was 2.3% for Q2. Net Working Capital (NWC) days improved to 63, and RoCE increased to 13.8%. The company continues to outperform industry growth.

A core strategy involves significant expansion into the high-margin MedTech segment through recent acquisitions, leveraging synergies with existing pharma distribution. Entero announced new acquisitions, mainly in MedTech (61% of total), targeting Rs. 1,000 Cr in revenue from these deals. These are set to boost gross and EBITDA margins.

Management expects to meet full-year guidance, forecasting accelerated growth, sustained margin improvement, and strong operating cash flow in H2 FY26. Entero's operational network expanded to 113 warehouses, serving over 85,300 retailers.